DA
TMO icon

Doliver Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Doliver Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.74M Sell
4,062
-7
-0.2% -$4.16K 0.6% 24
2026
Q2 		$2.04M Buy
4,069
+219
+6% +$105K 0.46% 31
2026
Q1 		$1.89M Buy
3,850
+39
+1% +$21.2K 0.43% 32
2025
Q4 		$2.21M Buy
3,811
+36
+1% +$20.4K 0.55% 26
2025
Q3 		$1.83M Buy
3,775
+33
+0.9% +$15.4K 0.47% 36
2025
Q2 		$1.52M Buy
3,742
+835
+29% +$349K 0.42% 39
2025
Q1 		$1.45M Buy
2,907
+104
+4% +$56.3K 0.41% 40
2024
Q4 		$1.46M Buy
2,803
+44
+2% +$24.2K 0.41% 41
2024
Q3 		$1.71M Sell
2,759
-78
-3% -$46.2K 0.47% 35
2024
Q2 		$1.57M Buy
2,837
+21
+0.7% +$12K 0.44% 37
2024
Q1 		$1.64M Sell
2,816
-18
-0.6% -$10.1K 0.46% 35
2023
Q4 		$1.5M Buy
2,834
+35
+1% +$16.9K 0.46% 39
2023
Q3 		$1.42M Sell
2,799
-33
-1% -$17.6K 0.43% 35
2023
Q2 		$1.48M Buy
2,832
+140
+5% +$75.5K 0.45% 32
2023
Q1 		$1.55M Buy
2,692
+120
+5% +$67.6K 0.49% 30
2022
Q4 		$1.42M Buy
2,572
+44
+2% +$23.3K 0.47% 33
2022
Q3 		$1.28M Buy
2,528
+168
+7% +$94K 0.47% 30
2022
Q2 		$1.28M Buy
2,360
+461
+24% +$254K 0.46% 38
2022
Q1 		$1.12M Buy
1,899
+163
+9% +$93.6K 0.35% 52
2021
Q4 		$1.03M Sell
1,736
-629
-27% -$393K 0.32% 53
2021
Q3 		$1.35M Buy
2,365
+203
+9% +$111K 0.45% 41
2021
Q2 		$1.09M Buy
2,162
+542
+33% +$256K 0.36% 47
2021
Q1 		$739K Buy
1,620
+805
+99% +$384K 0.27% 63
2020
Q4 		$380K Buy
+815
New +$382K 0.17% 89

Other funds holding TMO

DLA
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return
QPBE
Quintet Private Bank (Europe) Luxembourg $2.28B AUM 23.89% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $5.97B AUM 5.11% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.16B AUM 31.35% 1-Year Est. Return
AIM
Avity Investment Management Greenwich, Connecticut $1.6B AUM 32.15% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return

Doliver Advisors's TMO Position: Q3 2026 in Review

Doliver Advisors reduced its Thermo Fisher Scientific (TMO) stake by 0.17% in Q3 2026, selling an estimated $4.16K and leaving 4,062 shares worth $2.74M. The position accounts for 0.6% of the portfolio, ranked #24.

Doliver Advisors first reported a position in TMO in Q4 2020 and has held it in 24 quarters since. 134 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

  • Doliver Advisors held 4,062 shares of Thermo Fisher Scientific worth $2.74M as of Q3 2026.
  • Doliver Advisors sold 7 Thermo Fisher Scientific shares in Q3 2026, an estimated $4.16K.
  • Thermo Fisher Scientific made up 0.6% of Doliver Advisors's portfolio in Q3 2026, its #24 holding.
  • Doliver Advisors first reported a position in Thermo Fisher Scientific in Q4 2020 and has held it in 24 quarters since.
  • 134 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on Doliver Advisors's 13F filing for Q3 2026, filed 1 Oct 2026.